عنوان مقاله [English]
Introduction: Atherosclerosis is one of the most common causes of mortality in developed and developing countries, and chronic inflammation is an important risk factor for atherosclerosis. The study was aimed to investigate the effect of human lymphotropic virus type 1 (HTLV-1) infection on the progression of atherosclerosis in the HTLV-1 endemic area.
Materials and Methods: Of 50 patients in 4 groups including 14 coronary artery disease+HTLV-1+ patients, 8 CAD-HTLV-1+, 17 CAD+HTLV-1- subjects and 11 healthy controls (CAD-HTLV-1-), blood specimens were obtained. Then, Tax gene expression was evaluated via real-time PCR, TaqMan method. Furthermore, lipid factors such as cholesterol, triglyceride, LDL and HDL were measured as common risk factors of coronary artery disease.
Results: The HDL levels in CAD+HTLV-1+ group was significantly lower than the CAD-HTLV-1+ group (p=0.04). Total cholesterol in CAD+HTLV-1+ group was higher than CAD+HTLV-1- and CAD-HTLV-1- groups (p=0.001 and p=0.001). Also, total cholesterol in CAD-HTLV-1+ group was higher than CAD+HTLV-1- and healthy groups (p=0.001 and p=0.002). The LDL level in CAD+HTLV-1+ group was significantly higher than CAD+HTLV-1- group (p=0.001). Moreover, LDL level in CAD-HTLV-1+ group was higher than CAD+HTLV-1- group (p=0.01).
Conclusion: The HTLV-1 can alter the lipid profiles. Association between HDL, LDL, cholesterol and Tax showed that Tax as main virulence factor of virus by dysregulation of cytokines production, increasing of cholesterol, LDL and decreasing of HDL can facilitate the plaque formation in HTLV-1-infected patients.
1. Kandaswamy E, Zuo L. Recent Advances in Treatment of Coronary Artery Disease: Role of Science and Technology. Int J Mol Sc. 2018;19(2). doi: 10.3390/ijms19020424.
2. Layegh P, Shoeibi A, Nikkhah K, Ghabeli Juibary A, Raftari S, Darbarpanah S, et al. Can HTLV-1 infection be a potential risk factor for atherosclerosis? Intervirology. 2014;57(6):365-8. doi: 10.1159/000365785.
3. Hulten E, Mitchell J, Scally J, Gibbs B, Villines TC. HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies. Heart. 2009;95(22):1826-35.
4. Ismail A, Khosravi H, Olson H. The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target. Heart disease. 1999;1(4):233-40.
5. Fabricant CG, Fabricant J. Atherosclerosis induced by infection with Marek's disease herpesvirus in chickens. Am Heart J. 1999;138(5 Pt 2):S465-8.
6. Gonçalves DU, Proietti FA, Ribas JG, Araújo MG, Pinheiro SR, Guedes AC, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev. 2010;23(3):577-89. doi: 10.1128/CMR.00063-09.
7. Hedayati-Moghaddam MR, Tehranian F, Bayati M. Human T-Lymphotropic Virus Type I (HTLV-1) Infection among Iranian Blood Donors: First Case-Control Study on the Risk Factors. Viruses. 2015;7(11):5736-45. doi: 10.3390/v7112904.
8. Prado FLSD, Prado R, Ladeia AMT. Cardiovascular risk profile in patients with myelopathy associated with HTLV-1. Braz J Infect Dis. 2017;21(3):226-33. doi: 10.1016/j.bjid.2017.01.007.
9. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058-68.
10. Farid Hosseni R, Jabbari F, Shabestari M, Rezaee SA, Gharivani Y, Valizadeh N, et al. Human T Lymphotropic Virus Type I (HTLV-I) is a Risk Factor for Coronary Artery Disease. Iran J Basic Med Sci. 2013;16(3):217-20.
11. Farid R, Pishnamaz R. HTLV-I infection and accompanying diseases. Mashhad Med Faculty J.1381(76):129-40.
12. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004;45(7):1169-96.
13. Rafatpanah H, Torkamani M, Valizadeh N, Vakili R, Meshkani B, Khademi H, et al. Prevalence and phylogenetic analysis of HTLV-1 in a segregated population in Iran. J Med Virol. 2016;88(7):